These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
501 related items for PubMed ID: 25219538
1. Human stem cell-derived cardiomyocytes detect drug-mediated changes in action potentials and ion currents. Gibson JK, Yue Y, Bronson J, Palmer C, Numann R. J Pharmacol Toxicol Methods; 2014; 70(3):255-67. PubMed ID: 25219538 [Abstract] [Full Text] [Related]
2. Evaluation of Possible Proarrhythmic Potency: Comparison of the Effect of Dofetilide, Cisapride, Sotalol, Terfenadine, and Verapamil on hERG and Native IKr Currents and on Cardiac Action Potential. Orvos P, Kohajda Z, Szlovák J, Gazdag P, Árpádffy-Lovas T, Tóth D, Geramipour A, Tálosi L, Jost N, Varró A, Virág L. Toxicol Sci; 2019 Apr 01; 168(2):365-380. PubMed ID: 30561737 [Abstract] [Full Text] [Related]
3. Recording of multiple ion current components and action potentials in human induced pluripotent stem cell-derived cardiomyocytes via automated patch-clamp. Mann SA, Heide J, Knott T, Airini R, Epureanu FB, Deftu AF, Deftu AT, Radu BM, Amuzescu B. J Pharmacol Toxicol Methods; 2019 Apr 01; 100():106599. PubMed ID: 31228558 [Abstract] [Full Text] [Related]
4. CSAHi study: Detection of drug-induced ion channel/receptor responses, QT prolongation, and arrhythmia using multi-electrode arrays in combination with human induced pluripotent stem cell-derived cardiomyocytes. Kitaguchi T, Moriyama Y, Taniguchi T, Maeda S, Ando H, Uda T, Otabe K, Oguchi M, Shimizu S, Saito H, Toratani A, Asayama M, Yamamoto W, Matsumoto E, Saji D, Ohnaka H, Miyamoto N. J Pharmacol Toxicol Methods; 2017 Apr 01; 85():73-81. PubMed ID: 28163191 [Abstract] [Full Text] [Related]
10. Pharmacological enhancement of repolarization reserve in human induced pluripotent stem cells derived cardiomyocytes. Treat JA, Goodrow RJ, Bot CT, Haedo RJ, Cordeiro JM. Biochem Pharmacol; 2019 Nov 01; 169():113608. PubMed ID: 31465775 [Abstract] [Full Text] [Related]
11. Specific prediction of clinical QT prolongation by kinetic image cytometry in human stem cell derived cardiomyocytes. Pfeiffer ER, Vega R, McDonough PM, Price JH, Whittaker R. J Pharmacol Toxicol Methods; 2016 Nov 01; 81():263-73. PubMed ID: 27095424 [Abstract] [Full Text] [Related]
12. The action potential and comparative pharmacology of stem cell-derived human cardiomyocytes. Peng S, Lacerda AE, Kirsch GE, Brown AM, Bruening-Wright A. J Pharmacol Toxicol Methods; 2010 Nov 01; 61(3):277-86. PubMed ID: 20153443 [Abstract] [Full Text] [Related]
13. Proarrhythmic risk assessment using conventional and new in vitro assays. Goineau S, Castagné V. Regul Toxicol Pharmacol; 2017 Aug 01; 88():1-11. PubMed ID: 28506844 [Abstract] [Full Text] [Related]
15. Overexpression of KCNJ2 in induced pluripotent stem cell-derived cardiomyocytes for the assessment of QT-prolonging drugs. Li M, Kanda Y, Ashihara T, Sasano T, Nakai Y, Kodama M, Hayashi E, Sekino Y, Furukawa T, Kurokawa J. J Pharmacol Sci; 2017 Jun 01; 134(2):75-85. PubMed ID: 28615142 [Abstract] [Full Text] [Related]
17. Activation of the unfolded protein response downregulates cardiac ion channels in human induced pluripotent stem cell-derived cardiomyocytes. Liu M, Shi G, Zhou A, Rupert CE, Coulombe KLK, Dudley SC. J Mol Cell Cardiol; 2018 Apr 01; 117():62-71. PubMed ID: 29474817 [Abstract] [Full Text] [Related]